J. R. Caton

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein et al. · New England Journal of Medicine · 2001 · 1.7K citations

Medicine, Oncology, Surgery +16

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

Craig H. Reynolds, Coleman K. Obasaju, Michael J. Schell et al. · Journal of Clinical Oncology · 2009 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer

Guru Sonpavde, John M. Burke, J. R. Caton et al. · Annals of Oncology · 2011 · 143 citations

Medicine, Oncology, Pharmacology +16

Body composition analysis by bioelectrical impedance: effect of skin temperature.

J. R. Caton, P. A. Molé, W. C. Adams et al. · PubMed · 1988 · 96 citations

Life Sciences, Physiology, Bioenergetics +14